Coptis secures investment from Extens and Clearsight

By Julia Wray | Published: 9-Sep-2021

The cosmetic laboratories software company aims to accelerate its commercial and technical development planning

Cosmetic laboratories software company Coptis is joining forces with Extens, the first French fund dedicated to health care software publishers, and Swiss investment fund Clearsight to grow Coptis’ operations.

Established in 1999, Croissy-sur-Seine, France-based Coptis develops and markets specialised software to support cosmetic laboratories and raw material manufacturers during formulation and regulatory compliance stages.

This will mark the first time that Coptis has opened up its capital to Extens (which is making the second investment of its third fund currently being raised) and Clearsight, in order to accelerate its commercial and technical development planning.

On the heels of success in North America and Asia, Coptis intends to accelerate its deployment in both markets and consolidate its position as a leader in Europe.

The capital increase will also enable the company to develop its range of products by integrating new components into the existing software suite.

Anne Karagoz, President of Coptis, commented: "I have chosen Extens to support Coptis in the next stages of its development, and to help it thrive more rapidly in its own markets, as well as new markets.”

Karagoz said that Extens was chosen because it “is a fund dedicated to business software publishers and because the problems of publishers are very similar, even when the markets are different”.

“I also appreciate the Extens Club, which brings together the different company managers to discuss shared problems, which is what our customers do in the Coptis Users' Club.

“I sincerely believe that Extens and Clearsight will contribute to the success of Coptis in the coming years.”

You may also like